The Royal Devon University Healthcare NHS Foundation Trust is leading ground-breaking clinical research that has the ...

In this process, royalty recipients often face the issue where multiple small future royalty streams cannot fulfill ongoing large lump-sum R&D funding needs. The mismatch is where Royalty Pharma ...

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Irhythm Technologies (IRTC – Research Report), Vir ...

Delivering drugs to specific, hard-to-reach areas in the human body remains a challenge in drug development. Typically, drug molecules administered via pills or injections circulate randomly through ...

Our Parliamentary Affairs and Policy and Evidence teams have submitted their calls to the Government as part of the feedback process for the Spending Review.

Adding fluorine to drug molecules can be tricky, but is often worthwhile. Rachel Brazil talks to the chemists trying to tame ...

In a report released on February 5, Charles Weston from RBC Capital maintained a Buy rating on Sartorius Stedim Biotech (0RG8 – Research ...

While WrestleMania tends to steal the headlines each year, WWE's annual Royal Rumble premium live event (PLE) is actually the company's second most important show and arguably its most entertaining.

The road to WrestleMania 41 will officially kick off Saturday night when the 2025 Royal Rumble premium live event takes place in Indianapolis. Much of the attention will be on the men's and women ...

Overview: Bio-Gene Technology Limited is an agtech development company focused on developing and commercializing naturally derived insecticide products in Australia and internationally, with a ...

A busy working chapel, the Chapel Royal holds regular services which are open to the general public, as well as hosting some unique Royal services. If you would like to attend a service, click on ...

They show that he plans to divest stock holdings, including stakes in biotech firms CRISPR Therapeutics AG and Dragonfly Therapeutics. He’s also stepping down from roles at his law firm and at ...